Profile: Sterogene Bioseparations Inc. supplies novel reagents and systems to professionals in biotechnology & pharmaceutical processing. We now focus on novel technologies that could significantly improve the economy of producing biopharmaceuticals, such as an initial capture step for bioprocesses using large particles in a standard packed bed column. This eliminates expensive, rate-limiting recovery steps that are responsible for significant product losses, and achieves a major cost savings. Uniflow 4 is our agarose-based gel filtration medium with bead-shaped particles, suitable for gel filtration or as an affinity chromatography support. Its agarose base features unique polysaccharide composition that resists biological degradation. The additional crosslinking greatly enhances the mechanical and chemical stability of the matrix & eliminates the problem of biodegradation. Our Superflow 6 is an ideal support matrix for immobilizing biologically active substances. It exhibits very low nonspecific binding which is most important when small amounts of biologics need to be isolated by affinity methods.

The company was founded in 1985, has revenues of USD 1-5 Million, has ~20 employees.